Combination therapy with semaphorin-4D blockade (SEMA4D) and DC1 therapy Grant US-11660330-B2 United States of America 30 May 2023
Methods and compositions for enhancing the potency of superantigen mediated cancer… Grant US-11607452-B2 United States of America 21 Mar 2023
Treatment of cancer with a semaphorin-4D antibody in combination with an epigenetic… Grant US-11572408-B2 United States of America 07 Feb 2023